Neurology News

Avion Pharmaceuticals introduced its Parkinson’s disease treatment, Dhivy, the first carbidopa/levodopa fractional tablet intended to be divided, according to a press release.

Adults with two or more chronic conditions by middle age had an increased risk for dementia later in life, according to findings published in The BMJ.

Mobile stroke units were found to be cost-effective for tissue plasminogen activator-eligible patients, especially for those with no baseline disability, a speaker reported.

Swiss-based biopharmaceutical company AC Immune SA announced promising new interim data on the safety and efficacy of its ACI-35.030 vaccine for patients with early Alzheimer’s disease, according to a company press release.

Publicity surrounding FDA approval of Aduhelm for Alzheimer’s disease did not contribute to understanding of nor enthusiasm for the drug among middle-aged and older adults, according to survey results published in JAMA Network Open.

One-year survivors of MI experienced decreased risk for developing Parkinson’s disease and secondary Parkinsonism compared with the general population, researchers reported.

Children with ischemic stroke with large vessel occlusion appear to benefit from mechanical thrombectomy, researchers reported at the International Stroke Conference.

SwissNeuroRehab, a collaborative effort led by Lausanne University Hospital to advance neurorehabilitation treatment across continuum of care, has won the Innosuisse Flagship award, according to a release.

The FDA has granted approval to Amring Pharmaceuticals Inc. for its generic lamotrigine ODT, according to a press release.

The Senate has confirmed cardiologist Robert Califf, MD, MACC, to lead the FDA for a second time.